-
1
المؤلفون: J. Fayette, E.B. Saada, A. DeMontfort, A. Karabajakian, E.M. Neidhardt, C. Borel, M. Burgy, H. Carinato, J-P. Delord, S. Betrian, P. Toussaint, null T. Chatellier, null T. lharidon, G. Garin, null M. Bernardin, L. Jaouen, I. Sondarjee, D. Perol, J-Y. Blay
المصدر: Annals of Oncology. 33:S851-S852
مصطلحات موضوعية: Oncology, Hematology
-
2
المؤلفون: Benedetta Guani, Cherif Akladios, François Zaccarini, Vincent Balaya, S Bendifallah, Claire Sanson, Yohan Kerbage, F Guyon, S Betrian, Yohann Dabi, Elise Deluche, Pierre-Adrien Bolze, Patrice Mathevet, Fabrice Lecuru, L Drouin, Henri Azaïs
المصدر: Ovarian cancer.
مصطلحات موضوعية: medicine.medical_specialty, Bevacizumab, business.industry, General surgery, BRCA mutation, Cancer, medicine.disease, Debulking, Olaparib, Clinical trial, chemistry.chemical_compound, chemistry, medicine, Hyperthermic intraperitoneal chemotherapy, business, Ovarian cancer, medicine.drug
-
3
المؤلفون: Elise Deluche, Henri Azaïs, Cherif Akladios, Pierre-Adrien Bolze, François Zaccarini, Vincent Balaya, Yohan Kerbage, F Guyon, Fabrice Lecuru, Patrice Mathevet, HC Hsu, L Drouin, S Betrian, Yohann Dabi, S Bendifallah, Benedetta Guani, Claire Sanson, T Nikolova
المصدر: Ovarian cancer.
مصطلحات موضوعية: medicine.medical_specialty, Carcinosis, Bevacizumab, business.industry, General surgery, BRCA mutation, Debulking, medicine.disease, Olaparib, Clinical trial, chemistry.chemical_compound, chemistry, Medicine, Hyperthermic intraperitoneal chemotherapy, business, Ovarian cancer, medicine.drug
-
4
المؤلفون: A.M. Savoye, Christophe Caux, M.A. Mouret Reynier, Florence Joly, Elise Deluche, Pierre Saintigny, I.L. Ray-Coquard, D. Bello Roufai, Isabelle Treilleux, A-C. Hardy-Bessard, H. Péré, Antoine Angelergues, Fabrice Lecuru, S Betrian, M-C. Kaminsky-Forrett, L. Montané
المصدر: Annals of Oncology. 32:S770
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Locally advanced, Cancer, Ipilimumab, Hematology, medicine.disease, Immune system, medicine.anatomical_structure, Internal medicine, medicine, Nivolumab, business, Cervix, medicine.drug, Radio chemotherapy
-
5
المؤلفون: M.‐L. Piel‐Julian, M. Mahévas, J. Germain, L. Languille, T. Comont, M. Lapeyre‐Mestre, B. Payrastre, O. Beyne‐Rauzy, M. Michel, B. Godeau, D. Adoue, G. Moulis, L. Alric, S. Arista, L. Astudillo, L. Balardy, S. Betrian, D. Bonnet, C. Borel, D. Brechemier, N. Brun, M. Carreiro, B. Castel, L. Caudrelier, P. Cougoul, A. Danu, K. Delavigne, C. Dingremont, T. Faurie, F. Gaches, M.‐H. Gaspard, C. Gaudin, A. Godel‐Labouret, P. Giraud, S. Hadj‐Khelifa, B. Hebraud, S. Khatibi, L. Leplay, Y. Leveneur, N. Limal, S. Ollier, S. Madaule, B. Marchou, C. Martel, G. Martin‐Blondel, P. Montane De La Roque, M. Michaud, J. Moeglin, F. Nuccio, L. Prudhomme, G. Pugnet, C. Recher, V. Remy, L. Sailler, S. Sire, A. Sommet, S. Tavitian, M.‐F. Thiercelin‐Legrand, W. Vaillant
المساهمون: Centre hospitalier universitaire de Toulouse-Purpan, CHU Henri Mondor, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM, Service de Pharmacologie Médicale et Clinique, CHU Toulouse [Toulouse]-Centre d'Investigation Clinique, INSERM U1048 (I2CM), CHU de Toulouse, Laboratoire d'Hématologie, CHU Toulouse [Toulouse], Pagès, Nathalie, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service Pharmacologie Clinique [CHU Toulouse], Pôle Santé publique et médecine publique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Service Hématologie - IUCT-Oncopole [CHU Toulouse], Pôle Biologie [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Pôle IUCT [CHU Toulouse]
المصدر: Journal of Thrombosis and Haemostasis
Journal of Thrombosis and Haemostasis, Wiley, 2018, 16 (9), pp.1830-1842. ⟨10.1111/jth.14227⟩
Journal of Thrombosis and Haemostasis, 2018, 16 (9), pp.1830-1842. ⟨10.1111/jth.14227⟩مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Multivariate analysis, [SDV]Life Sciences [q-bio], Newly diagnosed, Comorbidity, 030204 cardiovascular system & hematology, Logistic regression, Gastroenterology, Severity of Illness Index, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, Epidemiology, Medicine, Humans, risk factors, Platelet, Mucosal bleeding, Aged, Aged, 80 and over, Purpura, Thrombocytopenic, Idiopathic, Receiver operating characteristic, business.industry, Anti-Inflammatory Agents, Non-Steroidal, Anticoagulants, Hematology, Middle Aged, platelet count, Immune thrombocytopenia, 3. Good health, [SDV] Life Sciences [q-bio], Cross-Sectional Studies, idiopathic thrombocytopenic purpura, ROC Curve, 030220 oncology & carcinogenesis, Area Under Curve, Female, epidemiology, hemorrhage, business, Selective Serotonin Reuptake Inhibitors
-
6
المؤلفون: K H Heider, Anne Quillet-Mary, J P Delord, Loic Ysebaert, Jean-Jacques Fournié, S Betrian
المساهمون: Centre de Physiopathologie Toulouse Purpan (CPTP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Claudius Regaud
المصدر: Blood Cancer Journal
Blood Cancer Journal, Nature Publishing Group, 2016, 6 (11), pp.e496-e496. ⟨10.1038/bcj.2016.106⟩مصطلحات موضوعية: 0301 basic medicine, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer, CD37, Pharmacology, 03 medical and health sciences, Preclinical research, 0302 clinical medicine, Combined treatment, hemic and lymphatic diseases, Medicine, Cytotoxicity, neoplasms, Letter to the Editor, ComputingMilieux_MISCELLANEOUS, biology, business.industry, Hematology, 3. Good health, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Cancer research, biology.protein, [SDV.IMM]Life Sciences [q-bio]/Immunology, Antibody, business, Idelalisib
-
7
المؤلفون: C. Nozal, P. Cougoul, Odile Beyne-Rauzy, Thibault Comont, S. Betrian, K. Delavigne, M. Picard, C. Nivet, M. Lemeu, J. Maquet
المصدر: La Revue de Médecine Interne. 39:A193
مصطلحات موضوعية: Gastroenterology, Internal Medicine